MedTrace Logo

Learning Through Play (LTP) Plus Group Cognitive Behaviour Therapy for Mothers of Young Children (ROSHNI-2)

NCT03379077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1006

Last updated 2022-04-29

No results posted yet for this study

Summary

The study has both quantitative and qualitative components.

The objective of the quantitative study is to:

Determine if supported implementation of the LTP plus programme improves infant development compared to standard implementation of the LTP plus programme.

The objective of the qualitative study is:

Process evaluation and finding out about implementation challenges (from the perspective of the mothers and the people delivering both the LTP plus and the supported implementation intervention).

Conditions

  • Mothers

Interventions

BEHAVIORAL

LTP Plus

LTP Plus is comprised of two components; Learning through play (LTP) and Cognitive Behavior Therapy (CBT). The LTP Plus is a low-literacy, sustainable program intended to provide parents with information on the healthy growth and development of their young children. The LTP research-based activities enhance children's development while simultaneously promoting attachment security through building parents' ability to read and be sensitive to their children's cues and through active involvement in their children's development. Plus the Thinking Healthy Program (THP) which adopts 'here and now' problem-solving approach. THP uses cognitive behavior therapy (CBT) techniques of active listening, changing negative thinking, and collaboration with the family.

Sponsors & Collaborators

  • Health and Nutrition Development Society

    collaborator UNKNOWN

  • Hincks Dellcrest Centre

    collaborator UNKNOWN

  • Pakistan Institute of Living and Learning

    lead OTHER

Principal Investigators

  • Nasim Chaudhry, (MRC Psych, FRC Psych, MD) · Pakistan Institute of Living & Learning

  • Nusrat Husain, (MD) · University of Manchester

  • Tayyeba Kiran, MS · Pakistan Institute of Living & Learning

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03379077 on ClinicalTrials.gov